PXL/HO/Cir-020/2020-21 Date: 11.05.2020
Hyderabad
Dear Sir/Madam,
Subject: High Commission of Canada looking for supplies of Pharmaceuticals from Health Canada/USFDA/WHO GMP/GMP approved manufacturers from India
We would like to inform members that the High Commission of Canada in India has approached Pharmexcil stating that they are looking for few pharmaceutical supplies from Health Canada certified/USFDA/WHO GMP/GMP approved manufacturers from India.
The High Commission of Canada is locating additional sources of supply of key pharmaceuticals from reputable and Health Canada approved pharmaceutical companies from India, who have the capacity to export pharmaceuticals to Canada at the present moment.
The table below lists the 28 key pharmaceuticals that are of immediate interest:
Atracurium
|
Meropenem — Injectable formats
|
Azithromycin — Injectable formats
|
Methotrimeprazine
|
Ceftriaxone — Injectable formats
|
Midazolam
|
Cisatracurium
|
Morphine — Injectable formats
|
Dexamethasone — Oral formats
|
Norepinephrine
|
Dexmedetomidine
|
Pancuronium
|
Epinephrine
|
Phenobarbital — Injectable formats
|
Ethambutol
|
Propofol
|
Fentanyl — Injectable formats
|
Rocuronium
|
Hydromorphone — Injectable formats
|
Salbutamol — Metered dose inhaler
|
Hydroxychloroquine
|
Single Ingredient Timolol Maleate — Ophthalmic Indications
|
Hydroxyurea
|
Succinylcholine chloride
|
Ketamine
|
Tocilizumab
|
Lorazepam
|
Vecuronium
|
Member companies possessing the certifications/approvals for the said products and having the capability to supply the products are requested to fill the attached format and submit to Mr.Sachin Balpande, Trade Commissioner at Sachin.Balpande@international.gc.ca.
The companies possessing certifications/approvals from Health Canada and any other international accreditations will be given preference.
For more information on the enquiry, please send email to Sachin.Balpande@international.gc.ca
With regards,
Uday Bhaskar
Director General
Encl: Format
|